Six year old review by Hybridian "..............but it still applies today .....with many advancements in the time..... we hold the key IMHO/ FDA just won't let us open the door YET......proteinomics is the key through Ryplazim....(3000 indications identified)...pbi 4050, 4547, etc. .... By memory , Hybridian called it in the area of $6.25 with about 700M shares outstanding....now Liminal with 23M out is worth what....all pumpers and bashers history will be in our cards and FDA are afraid because their decision will be the future controlling on more than 28,000 indications. .....this is their first test of the water and Ryplazim is the prize...this video well worth the review....
https://www.youtube.com/watch?v=TNUBQjQrQDs
foof